![Tafamidis / Transthyretin / Biology / Amyloid cardiomyopathy / Clinical trials / Amyloidosis / ClinicalTrials.gov / Familial amyloid cardiomyopathy / Transthyretin-related hereditary amyloidosis / Health / Cardiomyopathy / Medicine Tafamidis / Transthyretin / Biology / Amyloid cardiomyopathy / Clinical trials / Amyloidosis / ClinicalTrials.gov / Familial amyloid cardiomyopathy / Transthyretin-related hereditary amyloidosis / Health / Cardiomyopathy / Medicine](https://www.pdfsearch.io/img/71126a2eab3bdf7754a4b5edd097fa59.jpg) Date: 2014-04-18 19:15:57Tafamidis Transthyretin Biology Amyloid cardiomyopathy Clinical trials Amyloidosis ClinicalTrials.gov Familial amyloid cardiomyopathy Transthyretin-related hereditary amyloidosis Health Cardiomyopathy Medicine | | TTR-CM Phase 3 Study Fact Sheet Page 1 of 2 ATTR-ACT: Transthyretin Amyloid Cardiomyopathy Tafamidis Study A Phase 3 Clinical Study in Transthyretin Cardiomyopathy (TTR-CM)Add to Reading ListSource URL: www.amyloidosissupport.orgDownload Document from Source Website File Size: 160,51 KBShare Document on Facebook
|